Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any aortic valve disease in which the cause of the disease is a mutation in the SMAD6 gene.
Features include common findings: Calcification of the aorta, Coarctation of aorta, and Bicuspid aortic valve; and sometimes findings: Aortic valve stenosis, Aortic regurgitation, Aortic tortuosity, and Mitral regurgitation and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 7 | Aortic valve stenosis, Bicuspid aortic valve, Aortic regurgitation |
SMAD6 function has not been fully characterized.
Aortic valve disease 2 is associated with mutations in the SMAD6 gene on chromosome 15.
Genetic testing for SMAD6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for aortic valve disease 2 has been reported in the published literature.
Phenotype severity distribution: 3 common features.
No clinical trials have been registered for aortic valve disease 2.
279 publications have been identified in PubMed for aortic valve disease 2. Research spans Epidemiology / Natural History (28%), Clinical Trial Publication (26%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 71 | 28% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results
66 |
26% |
Laboratory research | 45 | 18% |
Research summaries | 39 | 15% |
Testing and diagnosis research | 19 | 7% |
Patient case studies | 7 | 3% |
New treatment approaches | 6 | 2% |
Other research | 4 | 2% |
Papazoglou AS (2026). [PMID: 41202890](https://pubmed.ncbi.nlm.nih.gov/41202890/). *Int J Cardiol*. [Review / Meta-Analysis]
Abplanalp WT (2026). [PMID: 41252200](https://pubmed.ncbi.nlm.nih.gov/41252200/). *J Clin Invest*. [Basic Science / Preclinical]
Kaya R (2026). [PMID: 41557136](https://pubmed.ncbi.nlm.nih.gov/41557136/). *J Ultrasound*. [Basic Science / Preclinical]
Bello JHSM (2026). [PMID: 42154879](https://pubmed.ncbi.nlm.nih.gov/42154879/). *Arq Bras Cardiol*. [Diagnostic / Biomarker]
Warraich N (2026). [PMID: 41138981](https://pubmed.ncbi.nlm.nih.gov/41138981/). *Am J Cardiol*. [Review / Meta-Analysis]
Lopez Santi P (2026). [PMID: 41104570](https://pubmed.ncbi.nlm.nih.gov/41104570/). *Eur Heart J*. [Basic Science / Preclinical]
Kany S (2026). [PMID: 41419685](https://pubmed.ncbi.nlm.nih.gov/41419685/). *Nat Genet*. [Basic Science / Preclinical]
Saleh D (2026). [PMID: 40675238](https://pubmed.ncbi.nlm.nih.gov/40675238/). *Ann Thorac Surg*. [Clinical Trial Publication]
Li N (2026). [PMID: 41985595](https://pubmed.ncbi.nlm.nih.gov/41985595/). *Int J Pharm*. [Basic Science / Preclinical]
Badwan O (2026). [PMID: 41005597](https://pubmed.ncbi.nlm.nih.gov/41005597/). *Am J Cardiol*. [Clinical Trial Publication]
AI-curated news mentioning aortic valve disease 2
Updated May 18, 2026
A study identifies rare type 1 collagen variants in early-onset bicuspid aortic valve disease, revealing clinical and genetic overlaps with Ehlers-Danlos syndrome and osteogenesis imperfecta. This research enhances understanding of these connective tissue disorders.
A recent study explores the rare co-presentation of bicuspid aortic valve aortopathy and PTEN mutations, providing new insights but not immediate clinical implications. This hypothesis-generating research may pave the way for future investigations into the genetic underpinnings of these conditions.